Please assess the completion status of the following clinical trial:

Trial Title: Combination Deplin® and Antidepressant Therapy for a Major Depressive Episode (MDE)- a Retrospective Analysis

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: RETROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Males or females age 18-70~* The active arm (Arm #1) includes randomly selected 100-125 charts of patients with a primary diagnosis of major depression and a CGI-S of ≥4 who began Deplin and SSRI or SNRI therapy at the same time beginning in January 2007 to the present; and, Control group (Arm #2) includes randomly selected 125-150 charts of patients with a primary diagnosis of major depression who began SSRI or SNRI therapy matched in severity (CGI-S of ≥4)~Exclusion Criteria:~* Folic acid \>400 mcg taken at any time during the study~* Psychotic features in the current episode or a history of psychotic features~* Any bipolar disorder (current or past) or any psychotic disorder (current or past)~* Current or past treatment with vagus nerve stimulation, ECT, or transcranial magnetic stimulation~* Antipsychotic therapy in conjunction with their antidepressant currently or in past 4 weeks

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Deplin + antidepressant (Type: None): Deplin in combination with a selective serotonin reuptake inhibitor (SSRI) or serotonin-norepinephrine reuptake inhibitor (SNRI)
- Antidepressant alone (Type: None): SSRI or SNRI alone

Based on this trial design, predict the completion outcome and termination type (if applicable).